ramipril · Rosemont Pharms · NDA 219757
Vostally
Earliest generic entry, as listed
16 Aug 2039
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 12343338.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12343338 | drug product, use U-4233 · sets the listed date | 16 Aug 2039 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 219757 · 001 · RLD · discontinued | solution, oral | 1MG/ML | 16 Aug 2039 |